Myocard (Doxazosin)

Doxazosin selectively blocks alpha‑1 adrenergic receptors on blood vessels and in the prostate. This blockade prevents norepinephrine‑induced vasoconstriction, leading to vessel dilation and reduced peripheral resistance, while also relaxing smooth muscle in the prostate and bladder neck, facilitating easier urination.

The dosage of Myocard is individualized by a qualified prescriber based on the patient’s medical condition, response, and tolerability. Physicians determine the appropriate starting dose and any subsequent adjustments, following clinical guidelines and patient monitoring.

Safety data for doxazosin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternatives with their healthcare provider.

To request Myocard, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with non‑selective alpha blockers, doxazosin offers a more targeted alpha‑1 blockade, resulting in fewer reflex tachycardia events. Relative to calcium‑channel blockers or ACE inhibitors, its primary benefit is concurrent treatment of BPH, making it a convenient option for patients needing both blood‑pressure control and urinary symptom relief.

Store Myocard tablets at temperatures below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Myocard is taken orally, usually once daily with or without food, as directed by the prescribing clinician. Patients should swallow the tablet whole with a full glass of water and follow any specific timing instructions provided by their healthcare professional.

Serious adverse events can include severe hypotension, syncope, worsening heart‑failure symptoms, and rare cases of liver injury or severe allergic reactions. Patients should seek immediate medical attention if they experience fainting, rapid weight gain, jaundice, or signs of anaphylaxis.

Myocard is contraindicated in patients with known hypersensitivity to doxazosin or any component of the formulation, and in those with severe hypotension or cardiogenic shock. Caution is also advised for individuals with significant liver disease, renal impairment, or a history of orthostatic dizziness.